Literature DB >> 17351483

Neuroimaging in tuberous sclerosis complex.

Aimee F Luat1, Malek Makki, Harry T Chugani.   

Abstract

PURPOSE OF REVIEW: In this review we discuss recent advances in the neuroimaging of patients with tuberous sclerosis complex (TSC), highlighting its application in improving clinical management, particularly in the case of intractable epilepsy. RECENT
FINDINGS: Progress in structural and functional imaging has led to further characterization of the brain lesions in TSC. New magnetic resonance imaging techniques that can delineate the extent of structural brain abnormalities in TSC have been developed. Diffusion tensor imaging unveils the microstructural abnormalities of the brain lesions and of the morphologically normal appearing white matter in TSC. It can potentially identify the epileptogenic zone. Positron emission tomography scanning with 2-deoxy-2-[18F]fluoro-D-glucose can assess the full extent of functional brain abnormalities in TSC. The use of alpha [11C] methyl-L-tryptophan positron emission tomography scanning has proven to be a useful tool in the identification of epileptogenic tubers and has improved the outcome of surgery for epilepsy in TSC.
SUMMARY: Major advances of neuroimaging in TSC have shown evidence of widespread structural and functional brain abnormalities. In TSC patients with intractable epilepsy, new neuroimaging modalities can now provide an accurate assessment of the epileptogenic zone, thereby permitting improved identification of patients who can have good seizure outcome following surgery for epilepsy.

Entities:  

Mesh:

Year:  2007        PMID: 17351483     DOI: 10.1097/WCO.0b013e3280895d93

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  19 in total

1.  Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex.

Authors:  Jurriaan M Peters; Mustafa Sahin; Vanessa K Vogel-Farley; Shafali S Jeste; Charles A Nelson; Matthew C Gregas; Sanjay P Prabhu; Benoit Scherrer; Simon K Warfield
Journal:  Acad Radiol       Date:  2012-01       Impact factor: 3.173

2.  Noninvasive Measurement of mTORC1 Signaling with 89Zr-Transferrin.

Authors:  Charles Truillet; John T Cunningham; Matthew F L Parker; Loc T Huynh; Crystal S Conn; Davide Ruggero; Jason S Lewis; Michael J Evans
Journal:  Clin Cancer Res       Date:  2016-12-22       Impact factor: 12.531

Review 3.  Emerging pharmacotherapies for neurodevelopmental disorders.

Authors:  Daniel Z Wetmore; Craig C Garner
Journal:  J Dev Behav Pediatr       Date:  2010-09       Impact factor: 2.225

Review 4.  Hereditary genodermatoses with cancer predisposition.

Authors:  Meg R Gerstenblith; Alisa M Goldstein; Margaret A Tucker
Journal:  Hematol Oncol Clin North Am       Date:  2010-10       Impact factor: 3.722

5.  Diffusion features of white matter in tuberous sclerosis with tractography.

Authors:  Michelle L Krishnan; Olivier Commowick; Shafali S Jeste; Neil Weisenfeld; Arne Hans; Matthew C Gregas; Mustafa Sahin; Simon K Warfield
Journal:  Pediatr Neurol       Date:  2010-02       Impact factor: 3.372

6.  Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.

Authors:  Àlex Rovira; María Luz Ruiz-Falcó; Elena García-Esparza; Eduardo López-Laso; Alfons Macaya; Ignacio Málaga; Élida Vázquez; Josefina Vicente
Journal:  J Neurooncol       Date:  2014-04-27       Impact factor: 4.130

7.  Hippocampal abnormalities in an MR imaging series of patients with tuberous sclerosis.

Authors:  H P P Gama; A J da Rocha; R M F Valério; C J da Silva; L A L Garcia
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-06       Impact factor: 3.825

8.  Magnetic resonance imaging and diffusion-weighted imaging of normal-appearing white matter in children and young adults with tuberous sclerosis complex.

Authors:  Sahayini Arulrajah; Gulhan Ertan; Lori Jordan; Aylin Tekes; Elizabeth Khaykin; Izlem Izbudak; Thierry A G M Huisman
Journal:  Neuroradiology       Date:  2009-07-15       Impact factor: 2.804

9.  Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients.

Authors:  William E Wu; Ivan I Kirov; Assaf Tal; James S Babb; Sarah Milla; Joseph Oved; Howard L Weiner; Orrin Devinsky; Oded Gonen
Journal:  Epilepsy Behav       Date:  2013-03-22       Impact factor: 2.937

10.  Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.

Authors:  Delia M Talos; David J Kwiatkowski; Kathia Cordero; Peter M Black; Frances E Jensen
Journal:  Ann Neurol       Date:  2008-04       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.